15. 11. 2013
Krka was awarded the First Prize for the best annual report among large companies in 2012 at the Best Annual Report competition organised by Finance daily newspaper for the fourteenth consecutive time. In addition, the professional committee awarded our company with a prize for the best annual report in the field of communication in 2012 among all companies.
14. 11. 2013
The Management Board of Krka held a press conference and presented to the public the performance results of the Krka Group and the Krka Company for the first nine months of 2013.
24. 9. 2013
To celebrate this year’s 25th anniversary of Krka’s antihypertensive medicines acting on the renin-angiotensin-aldosterone system (RAAS), Krka organised two international symposia on hypertension treatment The Challenges, Now and Then.
20. 9. 2013
More than 35 million people around the world suffer from dementia. Because the world’s population is ageing the number of people suffering from dementia increases every day and is expected to double by 2030 and triple by 2050, when it will affect 115 million people. As the illness progresses, patients require on-going daily care, which puts a lot of strain on the patient’s family and may be quite expensive.
4. 9. 2013
Krka's international symposium on hypertension treatment in Amsterdam held during the ESC Congress 2013
Hypertension is one of the most important factors in the development of cardiovascular disease. In caring for the health of patients, Krka continuously widens its extensive portfolio of medicines for treating hypertension and at the same time encourages exchange of experience among experts from various countries.